‘Miracle’ Alzheimer’s drug ‘triggers deadly brain bleeds in up to a third’, new study finds
AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...
pharmaphorum5d
Lilly touts new Kisunla regimen that reduces side effects
Eli Lilly says a new starting dose regimen for ... Simply shifting one vial of the anti-amyloid antibody from the first infusion to the third infusion of the titration phase of dosing – the ...
MedPage Today on MSN3d
Brain Edema, Imaging Abnormalities Reported for Alzheimer's Drug
Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...
Yahoo Finance22d
Eli Lilly Shifts Focus from GLP-1 Success to Neurological Breakthroughs
Feb 20 - Eli Lilly (LLY, Financial ... a monoclonal antibody whose drugs are hoped will clear amyloid plaques from the brain in the hope of preventing Alzheimer's onset. Early intervention ...
NBC New York22d
Eli Lilly aims to invest in ‘big problems hiding in plain sight' using obesity windfall
These are some of the areas where Eli Lilly, flush with cash from its GLP ... Kisunla is a monoclonal antibody that removes amyloid plaques from the brain, which are associated with the memory ...
360Dx4d
Neurology Blood Tests Primed to Improve Diagnosis, Management of Patients in Alzheimer's and Beyond
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
NBC Washington23d
Eli Lilly aims to invest in ‘big problems hiding in plain sight' using obesity windfall
Eli Lilly's GLP-1 drugs Mounjaro and Zepbound are ... Kisunla is a monoclonal antibody that removes amyloid plaques from the brain, which are associated with the memory-robbing disease.